Regulation of antioxidant system, lipids and fatty acid β-oxidation contributes to the cardioprotective effect of sodium tanshinone IIA sulphonate in isoproterenol-induced myocardial infarction in rats

Atherosclerosis

Volumn 230, Issue 1, 2013, Pages 148-156

  Wei, Bo ^a   You, Mei Gui ^a   Ling, Jing Jing ^a   Wei, Lin Lin ^a   Wang, Kai ^a   Li, Wen Wen ^a   Chen, Tong ^a   Du, Qian Ming ^a   Ji, Hui ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Dyslipidemia; Fatty acid oxidation; Isoproterenol; Myocardial infarction; Oxidative stress; Sodium tanshinone IIA sulphonate

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CARNITINE PALMITOYLTRANSFERASE I; HEME OXYGENASE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; TANSHINONE IIA; TANSHINONE IIA SULFONIC ACID; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FATTY ACID OXIDATION; HEART INFARCTION; HEART PROTECTION; MALE; MODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; UPREGULATION; ZYMOGRAPHY;

DYSLIPIDEMIA; FATTY ACID Β-OXIDATION; ISOPROTERENOL; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; SODIUM TANSHINONE IIA SULPHONATE;

ANIMALS; ANTIOXIDANTS; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; FATTY ACIDS; GENE EXPRESSION REGULATION; HEART; HEMODYNAMICS; ISOPROTERENOL; LIPIDS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; OXIDATION-REDUCTION; OXYGEN; PHENANTHRENES; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 84881622003     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.07.005     Document Type: Article

References (33)

1. Lopez A.D., Murray C.C. The global burden disease, 1990-2020. Nat Med 1998, 4:124-133.
2. Rajadurai M., Prince P.S.M. Preventive effect of naringin on lipid peroxides and antioxidants in isoproterenol-induced cardiotoxicity in Wistar rats: biochemical and histopathological evidences. Toxicology 2006, 228:259-268.
3. Rona G. Catecholamine cardiotoxicity. JMol Cell Cardiol 1985, 17:291-306.
4. Wang S.B., Tian S., Du G.H. Cardioprotective effect of salvianolic acid A on isoproterenol-induced myocardial infarction in rats. Eur J Pharmacol 2009, 615:125-132.
5. Zeller M., Masson D., Farnier M., Lorgis L., Deckert V., de Barros J.P.P., et al. High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarction. JAm Coll Cardiol 2007, 50(20):1948-1955.
6. Prabhu S.N., Shyamala Devi C.S. Effi{ligature}cacy of mangiferin on serum and heart tissue lipids in rats subjected to isoproterenol induced cardiotoxicity. Toxicology 2006, 228:135-139.
7. Yagi A., Fujimoto K., Tanonaka K., Hirai K., Takeo S. Possible active components of tanshen ( Salvia miltiorrhiza ) for protection of the myocardium against ischemia-induced derangements. Planta Med 1989, 55:51-54.
8. Chu T., Zhang Q., Li H., Ma W., Zhang N., Jin H., et al. Development of intravenous lipid emulsion of tanshinone IIA and evaluation of its anti-hepatoma activity invitro. Int J Pharm 2012, 424(1):76-88.
9. Yang R.F., Liu A.J., Ma X.J., Li L., Su D.F., Liu J.G. Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation. JCardiovasc Pharmacol 2008, 51(4):396-401.
10. Gong Z.W., Huang C., Sheng X.Y., Zhang Y.B., Li Q.Y., Wang M.W., et al. The role of tanshinone IIA in the treatment of obesity through peroxisome proliferator-activated receptor γ antagonism. Endocrinology 2009, 150(1):104-113.
11. Yang Y.C., Lii C.K., Lin A.H., Yeh Y.W., Yao H.T., Li C.C., et al. Induction of glutathione synthesis and heme oxygenase 1 by the fl{ligature}avonoids butein and phloretin is mediated through the ERK/Nrf2 pathway and protects against oxidative stress. Free Radic Bio Med 2011, 51:2073-2081.
12. Dyck J.R.B., Lopaschuk G.D. AMPK alterations in cardiac physiology and pathology: enemy or ally?. JPhysiol 2006, 574:95-112.
13. Panda V.S., Naik S.R. Cardioprotective activity of Ginkgo biloba phytosomes in isoproterenol-induced myocardial necrosis in rats: a biochemical and histoarchitectural evaluation. Exp Toxicol Pathol 2008, 60:397-404.
14. 2+-ATPase activities in normal, regenerating and malignant cells. BBA-Biomembranes 1982, 684(1):67-74.
15. Lowry O.H., Rosenbrough N.J., Farr A.I., Randall R.J. Protein measurement with the Folin phenol reagent. JBiol Chem 1951, 193:265-275.
16. Lopaschuk G.D., Ussher J.R., Folmes C.D.L., Jaswal J.S., Stanley W.C. Myocardial fatty acid metabolism in health and disease. Physiol Rev 2010, 90:207-258.
17. Meeran M.F.N., Prince P.S.M., Basha R.H. Preventive effects of N-acetyl cysteine on lipids, lipoproteins and myocardial infarct size in isoproterenol induced myocardial infarcted rats: an invivo and invitro study. Eur J Pharmacol 2012, 677:116-122.
18. Yeager J.C., Whitehurst M.E. Verapamil prevents isoproterenol induced cardiac failure in the rat. Life Sci 1982, 30(3):299-306.
19. Selaraj P., Pugalendi K.V. Efficacy of hesperidin on plasma, heart and liver tissue lipids in rats subjected to isoproterenol-induced cardiotoxicity. Exp Toxicol Pathol 2012, 64:449-452.
20. Rajadurai M., Prince P.S. Preventive effect of naringin on cardiac mitochondrial enzymes during isoproterenol-induced myocardial infarction in rats: a transmission electron microscopic study. JBiochem Mol Toxicol 2007, 21:354-361.
21. Saravanan G., Prakash J. Effect of garlic (Allium sativum) on lipid peroxidation in experimental myocardial infarction in rats. JEthanopharmacol 2004, 94:155-158.
22. Ji L.L., Stratman F.W., Lardy H.A. Antioxidant enzyme systems in rat liver and skeletal muscle: infl{ligature}uences of selenium defi{ligature}ciency, chronic training, and acute exercise. Arch Biochem Biophys 1988, 263:150-160.
23. + ATPase activity induced by free radicals and by ischemia of kidney. Am J Physiol 1988, 254:330-337.
24. Tan Y., Ichikawa T., Li J., Si Q., Yang H., Chen X., et al. Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells invitro and invivo. Diabetes 2011, 2:625-633.
25. Chiu P.Y., Chen N., Leong P.K., Leung H.Y., Ko K.M. Schisandrin B elicits a glutathione antioxidant response and protects against apoptosis via the redox-sensitive ERK/Nrf2 pathway in H9c2 cells. Mol Cell Biochem 2011, 350:237-250.
26. Hinkel R., Petersen B., Gottlieb E., Niemann H., Kupatt C. Therapeutic potential of HO-1 in ischemia reperfusion injury. Xenotransplantation 2012, 19:2-22.
27. Fyfe T., Baxter R.H., Cochran K.M., Booth E.M. Plasma-lipid change after myocardial infarction. Lancet 1971, 1:997-1001.
28. Assmann G., Schulte H., Funke H., von Eckardstein A. The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur Heart J 1998, 19:8-14.
29. 14C-labeled substrates in humans. JClin Invest 1987, 79:359-366.
30. Ussher J.R., Lopaschuk G.D. The malonyl CoA axis as a potential target for treating ischaemic heart disease. Cardiovasc Res 2008, 79:259-268.
31. Dyck J.R.B., Cheng J.F., Stanley W.C., Barr R., Chandler M.P., Brown S., et al. Malonyl coenzyme A decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation. Circ Res 2004, 94:78-84.
32. Garjani A., Andalib S., Biabani S., Soraya H., Doustar Y., Garjani A., et al. Combinedatorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat. Eur J Pharmacol 2011, 666:135-141.
33. Mohanty I., Arya D.S., Dinda A., Talwar K.K., Joshi S., Gupta S.K. Mechanisms of cardioprotective effect of Withania somnifera in experimentally induced myocardial infarction. Basic Clin Pharmacol Toxicol 2004, 94:184-190.